XClose

UCL Cancer Institute

Home
Menu

WP2 - Randomised trial of second line chemotherapy - rEECur

The focus of work package 2 is a clinical trial – rEECur.

The aim of the rEECur trial is to compare four different chemotherapy regimens to find out which is most effective and/or has fewest side effects.

The following deliverables will be completed for WP2:

Deliverable numberDescription*Month dueDocument link
D2.1rEECur protocol final version6Confidential
D2.2Registration of rEECur in ISRCTN6Confidential
D2.3Trial progress report12D2.3 (pdf)
D2.4Trial progress report24D2.4 (pdf)
D2.5Trial progress report36D2.5 (pdf)
D2.6Trial progress report48D2.6 (pdf)
D2.7Trial progress report60D2.7 (pdf)

 Some of the documents can be viewed by the public - click on the link in the Document link column to download the pdf.

*Month 1 is October 2013